炎症中枢神经系统中的前列腺素:潜在的治疗点
Chynna-Loren Sheremeta1,2, Sai Yarlagadda1,2, Mark L Smythe1
1Institute for Molecular Biosciences, The University of Queensland, St. Lucia, QLD 4072, Australia.
Current drug targets
|August 23, 2024
概括
前列腺素是中枢神经系统 (CNS) 中关键的炎症媒介,影响神经退行. 了解它们的双重神经保护/神经毒性作用可能会导致对阿尔茨海默氏症等疾病的新疗法.
科学领域:
- 神经科学是一个神经科学.
- 炎症研究 炎症研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经系统疾病是一个重大的全球健康挑战,有效的治疗方法有限.
- 炎症越来越被认为是中枢神经系统 (CNS) 疾病的关键因素.
- 前列腺素是从酸中获得的脂质媒介,在中枢神经系统炎症和平衡中起着至关重要的作用.
研究的目的:
- 审查前列腺素在神经退行性疾病中的多方面的作用.
- 为了检查前列腺素对阿尔茨海默氏症,多发性硬化症和肌缩侧面硬化症的影响.
- 讨论与前列腺素相关的agonists和antagonists的治疗潜力.
主要方法:
- 文献审查侧重于临床前和临床研究.
- 分析中枢神经系统中的前列腺素信号通路及其G蛋白受体.
- 对针对前列腺素通路的现有和潜在治疗剂的评估.
主要成果:
- 前列腺素在中枢神经系统中表现出神经保护性和神经毒性作用,这取决于它们的特定G蛋白结合受体.
- 这些受体表现出多样化的组织分布和信号传导机制.
- 有证据表明,前列腺素在阿尔茨海默氏症,多发性硬化症和ALS的发病过程中起着重要作用.
结论:
- 对中枢神经系统疾病中前列腺素作用的进一步研究对于开发有效疗法至关重要.
- 用特定的激动剂或对抗剂准前列腺素通路对未来的治疗策略有希望.
- 了解前列腺素受体信号传递是利用其在神经退行症治疗潜力的关键.
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
162
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
162
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
377
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
377
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
154
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
154
01:29Drug Delivery: Parenteral Route
447
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
447